{"id":"https://openalex.org/W2118908534","doi":"https://doi.org/10.1158/1535-7163.mct-14-0486","title":"P7170: A Novel Molecule with Unique Profile of mTORC1/C2 and Activin Receptor-like Kinase 1 Inhibition Leading to Antitumor and Antiangiogenic Activity","display_name":"P7170: A Novel Molecule with Unique Profile of mTORC1/C2 and Activin Receptor-like Kinase 1 Inhibition Leading to Antitumor and Antiangiogenic Activity","publication_year":2015,"publication_date":"2015-02-21","ids":{"openalex":"https://openalex.org/W2118908534","doi":"https://doi.org/10.1158/1535-7163.mct-14-0486","mag":"2118908534","pmid":"https://pubmed.ncbi.nlm.nih.gov/25700704"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-14-0486","doi":"https://doi.org/10.1158/1535-7163.mct-14-0486","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-14-0486","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040003868","display_name":"Archana Jalota\u2010Badhwar","orcid":"https://orcid.org/0000-0002-7785-0965","observed_orcids":["https://orcid.org/0000-0002-7785-0965"]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Archana Jalota-Badhwar","raw_affiliation_strings":["1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019345115","display_name":"Dimple R. Bhatia","orcid":"https://orcid.org/0000-0001-7916-6991","observed_orcids":["https://orcid.org/0000-0001-7916-6991"]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Dimple R. Bhatia","raw_affiliation_strings":["1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024165763","display_name":"Srinivas Reddy Boreddy","orcid":"https://orcid.org/0000-0002-7074-7498","observed_orcids":["https://orcid.org/0000-0002-7074-7498"]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Srinivas Boreddy","raw_affiliation_strings":["1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091172493","display_name":"Asavari Joshi","orcid":"https://orcid.org/0000-0001-7329-997X","observed_orcids":["https://orcid.org/0000-0001-7329-997X"]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Asavari Joshi","raw_affiliation_strings":["1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109955249","display_name":"Venkatraman Magesh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Magesh Venkatraman","raw_affiliation_strings":["1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037392395","display_name":"Nikesh Desai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Nikesh Desai","raw_affiliation_strings":["1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012443127","display_name":"Sarika K. Chaudhari","orcid":"https://orcid.org/0000-0002-2590-6365","observed_orcids":["https://orcid.org/0000-0002-2590-6365"]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sarika Chaudhari","raw_affiliation_strings":["1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071880673","display_name":"Julie S. Bose","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Julie Bose","raw_affiliation_strings":["1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029480229","display_name":"Lakshmi Sireesha Kolla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Lakshmi S. Kolla","raw_affiliation_strings":["1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008104789","display_name":"Vijaykumar Deore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Vijaykumar Deore","raw_affiliation_strings":["2Department of Medicinal Chemistry, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medicinal Chemistry, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056736352","display_name":"Nilambari Yewalkar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Nilambari Yewalkar","raw_affiliation_strings":["2Department of Medicinal Chemistry, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medicinal Chemistry, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051017511","display_name":"Sanjay Kumar","orcid":"https://orcid.org/0009-0002-5574-5547","observed_orcids":["https://orcid.org/0009-0002-5574-5547"]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sanjay Kumar","raw_affiliation_strings":["2Department of Medicinal Chemistry, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medicinal Chemistry, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012622153","display_name":"Rajiv Kumar Sharma","orcid":"https://orcid.org/0000-0002-1905-0986","observed_orcids":["https://orcid.org/0000-0002-1905-0986"]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rajiv Sharma","raw_affiliation_strings":["2Department of Medicinal Chemistry, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medicinal Chemistry, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004298709","display_name":"Anagha A. Damre","orcid":"https://orcid.org/0000-0002-5845-3163","observed_orcids":["https://orcid.org/0000-0002-5845-3163"]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Anagha Damre","raw_affiliation_strings":["3Department of Pharmacokinetics and Drug Metabolism, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Pharmacokinetics and Drug Metabolism, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Avinash More","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Avinash More","raw_affiliation_strings":["3Department of Pharmacokinetics and Drug Metabolism, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Pharmacokinetics and Drug Metabolism, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103361072","display_name":"Somesh Sharma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Somesh Sharma","raw_affiliation_strings":["1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017636838","display_name":"Veena R. Agarwal","orcid":"https://orcid.org/0000-0002-6904-8243","observed_orcids":["https://orcid.org/0000-0002-6904-8243"]},"institutions":[{"id":"https://openalex.org/I899992584","display_name":"Piramal (India)","ror":"https://ror.org/00vj60w13","country_code":"IN","type":"company","lineage":["https://openalex.org/I899992584"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Veena R. Agarwal","raw_affiliation_strings":["1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Pharmacology, Piramal Enterprises Ltd., Mumbai, India","institution_ids":["https://openalex.org/I899992584"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5017636838"],"corresponding_institution_ids":["https://openalex.org/I899992584"],"apc_list":null,"apc_paid":null,"fwci":0.643,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.6720946,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"14","issue":"5","first_page":"1095","last_page":"1106"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mtorc1-inhibition","display_name":"mTORC1 inhibition","score":0.9079999923706055},{"id":"https://openalex.org/keywords/mtorc2-inhibition","display_name":"mTORC2 inhibition","score":1.0},{"id":"https://openalex.org/keywords/alk1","display_name":"ALK1","score":0.9589999914169312},{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.7870000004768372},{"id":"https://openalex.org/keywords/antiangiogenic-activity","display_name":"antiangiogenic activity","score":0.8199999928474426},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9440000057220459},{"id":"https://openalex.org/keywords/p70s6k-phosphorylation","display_name":"p70S6K phosphorylation","score":0.9509999752044678},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.9760000109672546},{"id":"https://openalex.org/keywords/g1-s-cell-cycle-arrest","display_name":"G1/S cell cycle arrest","score":0.8709999918937683},{"id":"https://openalex.org/keywords/autophagy","display_name":"autophagy","score":1.0},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.8059999942779541},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.5870000123977661},{"id":"https://openalex.org/keywords/huvec-tube-formation","display_name":"HUVEC tube formation","score":0.7440000176429749}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5857862234115601},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5624025464057922},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5168617367744446},{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.5038990378379822},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4731641411781311},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.473135381937027},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40073609352111816},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.344561904668808},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33315378427505493},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.26171034574508667},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.20882576704025269},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13496825098991394},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001013","descriptor_name":"Aorta, Thoracic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D030301","descriptor_name":"Activin Receptors, Type II","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D030301","descriptor_name":"Activin Receptors, Type II","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D030301","descriptor_name":"Activin Receptors, Type II","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056945","descriptor_name":"Hep G2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056945","descriptor_name":"Hep G2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056945","descriptor_name":"Hep G2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061307","descriptor_name":"Human Umbilical Vein Endothelial Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061307","descriptor_name":"Human Umbilical Vein Endothelial Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061307","descriptor_name":"Human Umbilical Vein Endothelial Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-14-0486","doi":"https://doi.org/10.1158/1535-7163.mct-14-0486","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-14-0486","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:25700704","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25700704","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8399999737739563,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W126188432","https://openalex.org/W1975616120","https://openalex.org/W1983698019","https://openalex.org/W1984418041","https://openalex.org/W1994186909","https://openalex.org/W1996983679","https://openalex.org/W2011282245","https://openalex.org/W2014582878","https://openalex.org/W2021012077","https://openalex.org/W2025935112","https://openalex.org/W2029348880","https://openalex.org/W2035154619","https://openalex.org/W2035508274","https://openalex.org/W2037590098","https://openalex.org/W2054917860","https://openalex.org/W2066697766","https://openalex.org/W2068661213","https://openalex.org/W2076627331","https://openalex.org/W2078139160","https://openalex.org/W2079134955","https://openalex.org/W2087012714","https://openalex.org/W2087861588","https://openalex.org/W2089119460","https://openalex.org/W2099031084","https://openalex.org/W2102684430","https://openalex.org/W2108949860","https://openalex.org/W2113182862","https://openalex.org/W2113343850","https://openalex.org/W2113980589","https://openalex.org/W2117666643","https://openalex.org/W2117692326","https://openalex.org/W2126569401","https://openalex.org/W2127063807","https://openalex.org/W2127776747","https://openalex.org/W2153239771","https://openalex.org/W2154836325","https://openalex.org/W2156040421","https://openalex.org/W2158305336","https://openalex.org/W2163504684","https://openalex.org/W2165386262","https://openalex.org/W2167006483","https://openalex.org/W2242679990","https://openalex.org/W4238567307"],"related_works":["https://openalex.org/W2022984399","https://openalex.org/W2025935112","https://openalex.org/W3173414627","https://openalex.org/W4249615733","https://openalex.org/W2054117275","https://openalex.org/W1488655057","https://openalex.org/W2157618662","https://openalex.org/W3185746211","https://openalex.org/W2086338749","https://openalex.org/W2296384492"],"abstract_inverted_index":{"The":[0,215],"mTOR":[1,26],"pathway":[2,27],"is":[3,236],"often":[4],"upregulated":[5],"in":[6,109,127,148,167,173,178,198,224,240],"cancer":[7,55,96],"and":[8,21,91,104,120,131,223],"thus":[9],"intensively":[10],"pursued":[11],"as":[12,49,100],"a":[13,60,71,192,199],"target":[14,52],"to":[15,41,160,169,190,211],"design":[16],"novel":[17,61],"anticancer":[18],"therapies.":[19],"Approved":[20],"emerging":[22,51],"drugs":[23],"targeting":[24],"the":[25,31,42,86,152],"have":[28],"positively":[29],"affected":[30],"clinical":[32,233,243],"landscape.":[33],"Recently,":[34],"activin":[35],"receptor-like":[36],"kinase":[37],"1":[38],"(ALK1),":[39],"belonging":[40],"TGF\u03b2":[43],"receptor":[44],"family,":[45],"has":[46],"been":[47],"reported":[48],"an":[50,229],"for":[53,232],"antiangiogenic":[54,141,153],"therapy.":[56],"Here,":[57],"we":[58],"describe":[59],"orally":[62,208],"efficacious":[63],"compound,":[64],"P7170,":[65],"that":[66,137,151],"inhibits":[67],"mTORC1/mTORC2/ALK1":[68],"activity":[69,154],"with":[70,180,219],"potent":[72],"cell":[73,97,111],"growth":[74,112,196],"inhibition.":[75,113,162],"In":[76,94,122,143,183],"cell-based":[77],"assays,":[78],"P7170":[79,106,138,156,172,189,228],"strongly":[80],"inhibited":[81],"(IC50":[82],"<":[83],"10":[84,210],"nmol/L)":[85],"phosphorylation":[87],"of":[88,155,165,176,202],"p70S6K":[89],"(T389)":[90],"pAKT":[92],"(S473).":[93],"many":[95],"lines,":[98],"such":[99],"prostate,":[101],"ovarian,":[102],"colon,":[103],"renal,":[105],"treatment":[107],"resulted":[108],"marked":[110],"Furthermore,":[114],"it":[115],"induced":[116],"G1-S":[117],"cell-cycle":[118],"arrest":[119],"autophagy.":[121],"vitro":[123],"HUVEC":[124,149],"tube":[125],"formation,":[126],"vivo":[128,184,225],"Matrigel":[129],"plug,":[130],"rat":[132],"aorta":[133],"ring":[134],"assays":[135],"demonstrated":[136],"exhibited":[139],"significant":[140,193],"activity.":[142],"addition,":[144],"ALK1":[145,161,166],"knockdown":[146],"studies":[147,187],"confirmed":[150],"was":[157],"primarily":[158],"due":[159],"Strong":[163],"inhibition":[164,197],"addition":[168],"mTORC1/mTORC2":[170],"differentiates":[171],"its":[174],"mechanism":[175],"action":[177],"comparison":[179],"existing":[181],"inhibitors.":[182],"mouse":[185],"xenograft":[186],"revealed":[188],"exhibit":[191],"dose-dependent":[194],"tumor":[195,204],"broad":[200],"range":[201],"human":[203],"types":[205],"when":[206],"administered":[207],"at":[209],"20":[212],"mg/kg":[213],"doses.":[214],"distinctive":[216],"pharmacological":[217],"profile":[218],"favorable":[220],"pharmacokinetic":[221],"parameters":[222],"efficacy":[226],"makes":[227],"attractive":[230],"candidate":[231],"development.":[234],"It":[235],"currently":[237],"being":[238],"tested":[239],"phase":[241],"I":[242],"studies.":[244]},"counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}